Longevity Is Reshaping Patient Goals, RADIESSE Global Longevity Summit Keynote Says
Key Takeaways
- Patient desires have shifted from looking younger to communicating vitality, health, and confidence through facial appearance.
- Patients increasingly want aesthetic outcomes that complement investments in nutrition, exercise, sleep, and weight management.
- A tissue-focused approach to calcium hydroxylapatite treatment has largely replaced volume replacement alone.
The growing emphasis on longevity is changing what patients seek from aesthetic treatment, with more attention to looking healthy and confident rather than simply appearing younger, according to Daria Voropai, MBBS, BDS, who explored the psychology of aging and clinical experience with RADIESSE during a keynote presentation at the RADIESSE Global Longevity Summit.
In an interview with Modern Aesthetics about her presentation, “The Psychology of Aging and Real-World Experience with RADIESSE,” Dr. Voropai described a shift in the questions patients bring to aesthetic consultations. Instead of focusing on a particular age or reference photograph, she said, patients increasingly want their outward appearance to reflect how they feel and the effort they put into their health.
“Looking younger is a target, but looking like myself or confident is a signal that you express to the world around you,” she said.
Dr. Voropai pointed to patients who invest in sleep, strength training, and nutrition, as well as the growing use of glucagon-like peptide-1 (GLP-1)–based medications. Some patients, she said, feel that facial changes, particularly after substantial weight loss, do not reflect their improved fitness or sense of vitality. That disconnect can shape both treatment expectations and the language clinicians use during consultations.
From Volume Replacement to Tissue Quality
Dr. Voropai’s keynote also addressed the role of biostimulatory treatment in regenerative aesthetics. Discussing a patient who had experienced considerable weight loss, she emphasized that the objective was not necessarily to replace all lost facial volume. Rather, she described evaluating skin quality, tissue support, fat compartments, and the amount of additional volume needed.
Dr. Voropai discussed calcium hydroxylapatite (CaHA) in the context of collagen and elastin production and changes in the dermal environment. She contrasted this broader assessment with earlier approaches centered on placing hyaluronic acid filler at predetermined facial points. In her experience, patients increasingly ask whether clinicians can improve the condition of their own tissue before considering additional volume.
The summit also examined biological aging, menopause-related skin changes, and the potential relevance of regenerative approaches to aesthetic care. Dr. Voropai said the meeting brought together these themes around a wider discussion of longevity.
For aesthetic clinicians, her central message was that patient goals may be better understood through the relationship between appearance, self-perception, and perceived health—not chronological age alone.